Researchers at Helmholtz Munich and Ludwig-Maximilians-University (LMU) have shown how glial cells are reprogrammed into neurons via epigenetic modifications.
Over the next four years, Helmholtz Munich participates in a European research consortium, aiming to develop an innovative technology that could boost the regeneration of neurons in diseases that currently have limited therapeutic options. The…
A new paper published in Developmental Cell is the result of a collaboration between the Scialdone (Helmholtz Munich) and Srinivas (Oxford) groups. The two teams combined their respective experimental and computational expertise to unravel the…
Fostering creativity and out-of-the-box thinking – this is one of the key goals of the EU-funded project RepliFate spearheaded by Maria-Elena Torres-Padilla at Helmholtz Munich. The multidisciplinary and intersectoral consortium focuses on…
The rise of RNA viruses like SARS-CoV-2 highlights the need for new ways to fight them. RNA-targeting tools like CRISPR/Cas13 are powerful but inefficient in the cytoplasm of cells, where many RNA viruses replicate. Scientists from Helmholtz Munich…
Prof. Magdalena Götz about the fascinating research on reprogramming glia cells and cell replacement therapy in the field of brain injuries
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here: